Merck Just Made a Big Bet on a New Cancer Growth Engine
While the health care sector has struggled this year, that hasn’t been the case for all of Big Pharma. Shares of New Jersey-based Merck & Co. (NYSE: MRK) have outperformed the sector and the broad market with a more than 12% gain. The drugmaker’s stock recently got a shot in t
While the health care sector has struggled this year, that hasn’t been the case for all of Big Pharma.
Shares of New Jersey-based Merck & Co. (NYSE: MRK) have outperformed the sector and the broad market with a more than 12% gain. The drugmaker’s stock recently got a shot in t